Cerity Partners LLC lowered its holdings in Revvity Inc. (NYSE:RVTY - Free Report) by 42.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,310 shares of the company's stock after selling 6,900 shares during the period. Cerity Partners LLC's holdings in Revvity were worth $985,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of RVTY. Optiver Holding B.V. purchased a new stake in Revvity during the 4th quarter valued at about $33,000. Quarry LP boosted its holdings in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares during the period. Millstone Evans Group LLC purchased a new stake in Revvity during the 4th quarter valued at about $38,000. Vermillion Wealth Management Inc. purchased a new stake in Revvity during the 4th quarter valued at about $41,000. Finally, Continuum Advisory LLC boosted its holdings in Revvity by 39.3% during the 4th quarter. Continuum Advisory LLC now owns 471 shares of the company's stock valued at $53,000 after acquiring an additional 133 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on RVTY. Wells Fargo & Company dropped their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and decreased their target price for the stock from $145.00 to $115.00 in a research report on Thursday, May 1st. Raymond James Financial reissued an "outperform" rating and issued a $120.00 target price (down previously from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Robert W. Baird decreased their target price on Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Finally, Wall Street Zen lowered Revvity from a "buy" rating to a "hold" rating in a research report on Friday, July 18th. Five analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $123.07.
View Our Latest Research Report on RVTY
Revvity Price Performance
RVTY opened at $96.26 on Wednesday. The company has a 50-day moving average of $95.10 and a 200-day moving average of $103.86. The company has a market capitalization of $11.35 billion, a P/E ratio of 40.96, a PEG ratio of 2.29 and a beta of 0.98. Revvity Inc. has a 1-year low of $87.70 and a 1-year high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.99 and a current ratio of 3.58.
Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million during the quarter, compared to the consensus estimate of $662.30 million. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The company's revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.98 EPS. Equities analysts expect that Revvity Inc. will post 4.94 EPS for the current fiscal year.
Revvity Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.29%. Revvity's dividend payout ratio is currently 11.91%.
Revvity Profile
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Further Reading
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
